Valuation: Incyte Corporation

Market Cap 25.22B 22.13B 20.9B 19.05B 35.66B 2,418B 35.92B 250B 96.89B 1,235B 94.7B 92.66B 3,969B P/E 2026 *
55.5x
P/E 2027 * 17.2x
Enterprise Value 20.99B 18.42B 17.4B 15.86B 29.68B 2,012B 29.89B 208B 80.64B 1,028B 78.82B 77.12B 3,304B EV / Sales 2026 *
3.53x
EV / Sales 2027 * 3.07x
Free-Float
98.14%
Yield 2026 *
-
Yield 2027 * -
1 day-0.14%
1 week-1.09%
Current month+0.59%
1 month-4.45%
3 months+15.27%
6 months+34.39%
Current year+25.49%
1 week 123.03
Extreme 123.03
128.21
1 month 119.97
Extreme 119.97
130
Current year 89.25
Extreme 89.25
132.6
1 year 81.78
Extreme 81.78
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
22/09/26 Tax

Executive/Senior Manager

-920 0.0005%
15/09/26 Exercice

Chairperson

69,654 0.0344%
25/08/26 Tax

EVP, Human Resources

-504 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-1.09%+51.79%+110.98% 25.22B
-0.69%+0.76%+42.36%-5.25% 79.49B
+1.74%+28.32%+703.17%+101.34% 77.78B
-1.21%-0.34%-10.33%-29.82% 60.16B
-1.80%-2.15%-15.06%+26.38% 46.14B
+1.18%+3.03%+9.11%+169.01% 45.93B
+0.13%+5.09%+66.93%-11.20% 33.45B
-0.10%+3.69%+4.89%+166.22% 22.15B
+0.05%-2.42%+57.59%+97.38% 15.25B
-1.05%-1.74%+33.57%+141.69% 12.96B
Average -0.22%+2.53%+94.40%+76.67% 41.85B
Weighted average by Cap. -0.14%+4.73%+148.44%+57.53%

Financials

2026 *2027 *
Net sales 5.94B 5.21B 4.92B 4.49B 8.4B 570B 8.46B 58.93B 22.82B 291B 22.31B 21.83B 935B 6.27B 5.5B 5.19B 4.73B 8.86B 600B 8.92B 62.13B 24.07B 307B 23.52B 23.01B 986B
Net income 466M 409M 386M 352M 659M 44.65B 663M 4.62B 1.79B 22.81B 1.75B 1.71B 73.31B 1.5B 1.31B 1.24B 1.13B 2.11B 143B 2.13B 14.84B 5.75B 73.24B 5.62B 5.49B 235B
Net Debt -4.23B -3.71B -3.51B -3.19B -5.98B -405B -6.02B -41.95B -16.25B -207B -15.88B -15.54B -666B -5.99B -5.26B -4.97B -4.52B -8.47B -574B -8.53B -59.41B -23.01B -293B -22.49B -22.01B -943B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
25/09/26 $124.14 -0.24% 452,142
24/09/26 $124.44 -0.16% 1,404,535
23/09/26 $124.64 -1.80% 1,534,432
22/09/26 $126.93 +1.83% 1,647,176
21/09/26 $124.65 -0.53% 1,270,531
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
124.44USD
Average target price
127.74USD
Spread / Average Target
+2.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock